United States · Series B startup
3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$121Mraised across 3 rounds since 2012, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $71M sold, first sale Aug 2017
From a historical funding record
No investor was named in the report.
Reported by sec.govSEC filing: $500K sold, first sale Nov 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Merck Global Health Innovation Fund
Easton Capital
Core VenturesCore Ventures/ Merck Global HealthGakasaVinik FamilyMissing a round, or an investor who was in one? Tell us.
These 2 firms list ElectroCore as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
ElectroCore's investors include Merck Global Health Innovation Fund, Easton Capital, Core Ventures, Core Ventures/ Merck Global Health and Gakasa, and 1 more on record.
ElectroCore has raised $121M across 3 rounds since 2012.
ElectroCore's most recent round was a Series B of $70M in Nov 2017.
Its most recent round, $70M in Nov 2017, is also its largest on record.
ElectroCore's first round on record, in Jun 2014, was backed by Merck Global Health Innovation Fund, Easton Capital and Core Ventures.
ElectroCore's latest named round is a Series B, in Nov 2017.
ElectroCore is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
